Serology study of healthcare workers following a hospital-based outbreak of COVID-19 in North West Tasmania, Australia, 2020.
暂无分享,去创建一个
F. Johnston | M. Sheel | Michelle Mcpherson | N. Stephens | M. Veitch | L. Cooley | Belinda McEwan | Kylie J. Smith | M. T. Marfori
[1] L. Ceretta,et al. A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19 , 2022, Journal of Clinical Virology.
[2] J. Carlin,et al. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia After the First Epidemic Wave in 2020: A National Survey , 2022, Open forum infectious diseases.
[3] N. French,et al. The seroprevalence of SARS-CoV-2 during the first wave in Europe 2020: A systematic review , 2021, PloS one.
[4] Kylie Smith,et al. Lessons learnt from the first large outbreak of COVID-19 in health-care settings in Tasmania, Australia , 2021, Western Pacific surveillance and response journal : WPSAR.
[5] T. Seemann,et al. COVID-19: Integrating genomic and epidemiological data to inform public health interventions and policy in Tasmania, Australia , 2021, Western Pacific surveillance and response journal : WPSAR.
[6] M. Gönen,et al. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis , 2021, Clinical Microbiology and Infection.
[7] Y. Kawaoka,et al. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months , 2021, EClinicalMedicine.
[8] Bjoern Peters,et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection , 2021, Science.
[9] R. Tibshirani,et al. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome , 2020, Science Immunology.
[10] P. Galanis,et al. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis , 2020, Journal of Hospital Infection.
[11] P. Escribano,et al. Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19 , 2020, Scientific Reports.
[12] M. Nussenzweig,et al. Evolution of Antibody Immunity to SARS-CoV-2 , 2020, bioRxiv.
[13] C. Cordon-Cardo,et al. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months , 2020, Science.
[14] M. Malim,et al. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans , 2020, Nature Microbiology.
[15] M. Shariff,et al. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic , 2020, International Journal of Infectious Diseases.
[16] P. G. Choe,et al. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection , 2020, Emerging infectious diseases.
[17] G. Rodger,et al. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison , 2020, The Lancet Infectious Diseases.
[18] M. Jorge Cardoso,et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study , 2020, The Lancet Public Health.
[19] H. Goossens,et al. Monitoring approaches for health-care workers during the COVID-19 pandemic , 2020, The Lancet Infectious Diseases.
[20] Devy M. Emperador,et al. Antibody tests for identification of current and past infection with SARS‐CoV‐2 , 2020, The Cochrane database of systematic reviews.
[21] Y. Pan,et al. Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients , 2020, Clinical Infectious Diseases.
[22] Andrea Benedetti,et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis , 2020, BMJ.